{"id":1241,"date":"2025-10-07T10:16:25","date_gmt":"2025-10-07T10:16:25","guid":{"rendered":"https:\/\/network.rvrising.com\/?p=1241"},"modified":"2025-10-07T10:16:25","modified_gmt":"2025-10-07T10:16:25","slug":"mltx-investors-have-opportunity-to-join-moonlake-immunotherapeutics-fraud-investigation-with-the-schall-law-firm","status":"publish","type":"post","link":"https:\/\/www.rvrising.com\/news\/business\/mltx-investors-have-opportunity-to-join-moonlake-immunotherapeutics-fraud-investigation-with-the-schall-law-firm\/","title":{"rendered":"MLTX Investors Have Opportunity to Join MoonLake Immunotherapeutics Fraud Investigation with the Schall Law Firm"},"content":{"rendered":"

LOS ANGELES<\/span>, Oct. 6, 2025<\/span> \/PRNewswire\/ —\u00a0<\/strong>The Schall Law Firm<\/a>, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of\u00a0MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX<\/a>) for violations of the securities laws.<\/p>\n

\n

The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. MoonLake touted the strength of its trial designs for sonelokimab, expressing confidence in their plans for potential intercurrent events after treatment begins. On September 29, 2025, the Company announced that during its VELA-2 trial, “intercurrent events in the higher-than-expected placebo arm precluded the study from achieving statistical significance in the week 16 primary endpoint using the composite strategy (HiSCR75, delta to placebo of 9%.” Based on this news, shares of MoonLake fell by about 90% on the same day.<\/p>\n

If you are a shareholder who suffered a loss, click here to participate<\/a>.<\/p>\n

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at\u00a0www.schallfirm.com<\/a>, or by email at\u00a0[email\u00a0protected]<\/span><\/a>.<\/p>\n

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p>\n

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

CONTACT:<\/b><\/p>\n

The Schall Law Firm\u00a0
Brian Schall, Esq.
310-301-3335
[email\u00a0protected]<\/span><\/a>
www.schallfirm.com<\/a><\/p>\n

SOURCE The Schall Law Firm<\/p>\n

\"\"This release is auto-published via PR Newswire; our journal is not responsible for the content.<\/b><\/p>\n<\/div>\n

Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES, Oct. 6, 2025 \/PRNewswire\/ —\u00a0The Schall Law Firm, a national shareholder rights litigation firm, announces that<\/p>\n","protected":false},"author":1,"featured_media":1242,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8,92],"tags":[130],"class_list":["post-1241","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-pr-newswire","tag-the-schall-law-firm"],"_links":{"self":[{"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/posts\/1241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/comments?post=1241"}],"version-history":[{"count":1,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/posts\/1241\/revisions"}],"predecessor-version":[{"id":1266,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/posts\/1241\/revisions\/1266"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/media\/1242"}],"wp:attachment":[{"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/media?parent=1241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/categories?post=1241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rvrising.com\/news\/wp-json\/wp\/v2\/tags?post=1241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}